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Summary 
Inducible nitric oxide synthase (iNOS) can be expressed by many types of mammalian cells in 
response to diverse signals acting synergistically,  including cytokines and microbial products. 
We previously showed that induction of iNOS in mouse macrophages by interferon 3' (IFN-3') 
and lipopolysaccharide  (LPS) was at the transcriptional levd. From a mouse genomic library, 
we now cloned a 1,749-bp fragment from the 5'-flanking region of the iNOS gene, and used 
$1 nuclease mapping and primer extension to identify the mRNA transcription start site within 
it. The mRNA initiation site is preceded by a TATA box and at least 22 oligonucleotide elements 
homologous to consensus sequences for the binding of transcription factors  involved in the 
inducibility of other genes by cytokines or bacterial products. These include 10 copies of IFN-3" 
response dement; 3 copies of 3'-activated site; 2 copies each of nuclear factor-~B, IFN-ot-stimulated 
response element, activating protein 1, and tumor necrosis factor response element; and one X 
box. Plasmids in which all or the downstream one half or one third of this region of iNOS 
were linked to a reporter gene encoding Chloramphenicol acetyitransferase were transfected into 
cells of the RAW264.7 macrophage-like line. All these constructs conferred inducibility of the 
iNOS promoter by LPS, but only the construct containing all 1,749 bp conferred synergistic 
inducibility by IFN-3" plus LPS. 
N 
'itric oxide (NO),  a short-lived, radical gas, acts as an 
intercellular messenger in most or all mammalian organs, 
participating in vascular homeostasis, neurotransmission, and 
antimicrobial defense (1). Three genes encode NO synthases 
(NOS) of two biochemical types. Neuronal and endothelial 
NOS are constitutive but dormant until activated briefly by 
Ca  2+  transients  that  sustain  the binding of calmodulin. 
These have been termed cNOS (1). A third NOS is expressed 
only after transcriptional induction (2). Once synthesized, 
this NOS is active for prolonged periods, perhaps because 
it binds calmodulin without a requirement for elevation of 
Ca  2+ above the levels in resting ceils (3). Termed inducible 
NOS (iNOS), the latter form of the enzyme has been purified 
(4-6) and cloned (2, 7, 8) from mouse macrophages, iNOS 
mediates some of the cytotoxic action of activated  macro- 
phages, and when expressed in vascular smooth muscle, en- 
dothdium and/or liver, may play a key role in septic shock (9). 
Three considerations have focused our interest on the iNOS 
promoter. First, immunologically  inducible, high-output NO 
production is widely distributed, having been observed not 
only in macrophages, endothelium, vascular smooth muscle, 
and hepatocytes, but also in tumor cells, fibroblasts,  mesan- 
gial cells, astrocytes, keratinocytes,  and cardiac myocytes (1, 
10-12). Second, in all these cells, maximal induction of iNOS 
depends on synergistic combinations of stimuli, the most effec- 
tive ones varying with the cell type. For mouse macrophages, 
synergistic inductive combinations include IFN-3', IFN-cr or 
IFN-B plus LPS, or IFN-3' plus TNF-oe or -lJ (13-16), whereas 
for rat and human hepatocytes,  four signals  are required: 
IFN-3', TNF-oe, IL-1/L and LPS (17). Finally, iNOS is sub- 
ject to immunologic suppression, for example, by TGF-B (18), 
macrophage deactivation factor (18), and IL-4 (19). We have 
taken steps toward analyzing the molecular mechanisms by 
which iNOS is induced and suppressed, by cloning the pro- 
moter of the mouse iNOS gene, and distinguishing regions 
within it that are responsive to LPS alone or to the syner- 
gistic contribution of IFN-3'. 
Materials and Methods 
Materials.  Recombinant marine IFN-3, (5  x  l& U/ml) was 
generously  provided  by Genentech (South San Francisco, CA). LPS 
was  purchased from  Sigma Chemical Co.  (St. Louis, MO). 
Thioglycollate broth was from Difco Laboratories Inc. (Detroit, 
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Cell Culture.  Peritoneal macrophages were isolated from CD-1 
mice (Charles River Laboratories, Wilmington, MA) 4 d after an 
intraperitoneal injection of thioglycollate broth (15), RAW 264.7, 
a mouse macrophage cell line, was obtained from the American 
Type Culture Collection,  Rockville, MD.  Cells were grown in 
RPMI 1640 (KC Biological, Lenexa, KS) with 10% fetal bovine 
serum and antibiotics (complete medium) at 37~  in 5% CO2 (4). 
Nitrite accumulation in culture medium was measured as before (15). 
Preparation of Probes.  For DNA probes, template DNA frag- 
ments were reacted with Khnow enzyme, random primers, dATP, 
dGTP,  dTTP,  and  [3~P]dCTP, according  to  the  instructions 
provided with the Prime-a-Gene kit (Promega Corp.,  Madison, 
WI). For oligonuchotide probes, specific oligonucleotides  were 
5'-end-labeled with ~-[32p]ATP  by T4 polynucleotide  kinase. 
Cloning of 5'-Flanking Region  from iNOS.  The 5'-fragment of 
iNOS eDNA (nucleotides 1-845,  see reference 2), comprised of 
255 bp of 5'-untranslated  region  and  590 bp of NI-I2-terminal 
coding region, was isolated from the clones described (2). This frag- 
ment served as a template to prepare a DNA probe for screening 
20,000 cosmid colonies from a mouse genomic library provided 
byJ. Mudgett (Merck Research Laboratories, Rahway, NJ). A posi- 
tive clone was selected  and its genomic DNA was digested by HinclI. 
The products were subjected to Southern blot with a second DNA 
probe prepared  from  only the  5'-untranslated  region  of iNOS 
(nucleotides 1-200, see reference 2). A unique fragment of 1.7 kb 
hybridized and was subcloned into pBluescript SK+ at the HinclI 
site to form pUP1 and pUPlr (in the two orientations).  These 
plasmids were used to sequence the 1,749-bp insert (-1588 to +161) 
by the dideoxy method (20). 
Constructs of iNOS Promoter  Fused  with Chloramphenicol  Acetyltrans- 
)'erase (CAT) Gene.  The 1,749-bp fragment of the 5'-flanking re- 
gion of iNO$ was excised from plasmid pUP1 and inserted, with 
the same orientation,  into pCAT-Basic (Promega Corp.) upstream 
of the promoterless CAT gene to form the construct pliNOS-CAT. 
Portions were removed from pliNOS-CAT to form p2iNOS-CAT, 
p3iNOS-CAT, and p5iNOS-CAT, as specified below. 
Initiation Site  for mRNA.  This was determined by $1 nuclease 
mapping with a single-stranded, end-labded DNA probe (21) and 
by primer extension (22) with the following modifications: (a) the 
primer and KNA template were hybridized in buffer without for- 
mamide at 65~  for 2 h; and (b) avian myeloblastosis virus reverse 
transcriptase was used. 
Transient Transfection  of  RAW264.7 Cells  and CAT Assays.  RAW 
264.7 cells were transfected by a modification of the DEAE-dextran 
procedure (23). After cells were washed twice with RPMI, 10/~g 
of plasmid DNA was added per I0  r cells in 1 ml of RPMI without 
serum prewarmed  to 37~  and containing  DEAE-dextran  (250 
/~g/ml) and 50 mM Tris (pH 7.4). The suspension was incubated 
at 37~  for 45-60 rain followed  by a l-rain shock with 10% DMSO 
at room temperature.  The cells were washed, distributed  to 100- 
ram plates, each with about 5  x  106 cells in 10 ml of complete 
medium,  and incubated at 37~  in 5% CO2. At least 24 h later, 
the medium was changed, and IFN-~/and/or LPS were added to 
some plates. About 14 h later, the cells were washed with ice-cold 
PBS, resuspended in 0.25 mM Tris (pH 7.8), and subjected to three 
cycles of freezing and thawing. Lysates were centrifuged (11,700 g 
for 10 min at 4~  The supernatant was heated at 65~  for 10 rain 
to inactivate CAT inhibitors  and then centrifuged  as above. The 
supernatant  was assayed for CAT activity by TIC method (24). 
Protein  content was determined  as described by Bradford (25). 
Results 
Cloning and Analysis of a 1,749-bp Y-Flanking Region of 
iNOS.  A  1,749-bp HinclI fragment at the 5'-flanking re- 
gion of iNOS was cloned from a mouse genomic library and 
sequenced (Fig. 1 A). Both $1 nuclease mapping and primer 
extension (Fig.  2) identified the same initiation  site (desig- 
nated  +1 in Fig.  1 A) 30 bp downstream of a TATA box. 
The TATA box is preceded by a multitude of oligonucleotide 
elements homologous to consensus sequences for binding of 
transcription  factors involved in cytokine or LPS induction 
of other genes,  including  sequences specified  as IFN-y re- 
sponse element (~/-IRE) (10 copies) (26, 27); ~/-activated  site 
(GAS) (3 copies) (26, 28); nuclear factor-gB (NF-r,B) (2 copies) 
(29); IFN-c~-stimulated response element (ISRE) (2 copies) 
(28); activator protein 1 (AP-1) (2 copies) (30); TNF response 
element (TNF-RE) (2 copies) (31); and X box (1 copy) (26, 
32). 
$1 nuclease mapping  and primer extension (Fig.  2) rein- 
forced the previous conclusion (2) that no detectable mKNA 
for iNOS accumulates in RAW 264.7 macrophage-like cells 
or primary peritoneal macrophages without induction. Treat- 
ment with IFN-y and LPS led to transcription of iNOS from 
the same initiation  site in both cell populations. 
Promoter Activity of the Full-Length 1,749-bp Fragment and 
Its 5'-Truncated Constructs.  The 1,749-bp 5'-flanking region 
of iNOS was fused to a promoterless CAT reporter gene in 
the vector pCAT-Basic  to form the construct pliNOS-CAT. 
This construct and the vector only were transfected into RAW 
264.7  ceils.  As  reflected  by  CAT  activity,  the  1,749-bp 
5'-flanking region of iNOS conferred responsiveness to the 
combination of IFN-3, and LPS (Table 1 and Fig. 3). By it- 
self,  LPS  induced  promoter  activity  in  a  concentration- 
dependent manner.  IFN-3' alone was ineffective.  However, 
IFN-3, synergistically enhanced the response to LPS (Fig. 4 A). 
Downstream portions of the 1,749-bp region were linked 
to the CAT gene to form the constructs p2iNOS-CAT and 
p3iNOS-CAT (Fig.  1 B). Both conferred inducibility by LPS 
in a concentration-dependent  fashion. However, in contrast 
to pliNOS-CAT,  the constructs lacking the upstream half 
of the  1,749-bp fragment  did not respond to the addition 
of IFN-y  (Fig.  4, B  and C). 
$1 nuclease mapping  confirmed that  the mKNA  initia- 
tion site of the CAT transcript in the cells transfected with 
pliNOS-CAT was at the same location as that for iNOS tran- 
script itself in untransfected cells, and that no detectable CAT 
mKNA synthesis was initiated in transfected ceils without 
induction by IFN-y and LPS (data not  shown). 
Discussion 
The 1,749-bp 5'-flanking region identified here as the pro- 
moter of the iNOS gene contains a remarkable multiplicity 
of consensus sequences for the binding of transcription factors 
involved in the induction  of other genes by cytokines and 
bacterial products,  such as IFN-% IFN-c~,  TNF, IL-2, and 
LPS.  In addition,  regions.of GT- or AC-repeats considered 
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-  1588  tCTTTGATATGCTGAAATCCATAAGCTGTGTG~qT~GTGCAAGTOTGCA 
-1539 TGCGCATGT  GTGCACATGAGTGTGCAGGTATATGTAGGAGCTAGAAGACAATCTCAGCTC 
-1479 TTGTTTC  C  CAGGTTAC  CCAGCAT  CTCTCAC  CAGC~CTAGTAGGCTAGGCT 
T-IRE(8/8) 
-1419 GGCTGGCCAGCAAACC  CTAGGCATATTC  CTGTCTTT____A____A____A____~CCCAGAACTTATTGCAAGT 
7-IRE (K/8) 
-1359  GTGTGTCAC  CACACCCAGCATTTTATCATTGACCTATTGACTGOTGTOTGTGTGTGTGTG 
-1298  TGTGTTTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGTOTGTOTGCGTGTGTAAATT 
-1239  C  CTTATCTCACCAACCCATGCC  CAGCTTTTGAACTTAGGTCCTTGTACATGCAAGGCAAG 
-I179 CACTTTAC  CAACTGAGCCATCTCCCCAGC  C  CAATTAC~___~__T~TGTAATTCATTTATTCA 
y-IRE  (~18) 
AP-1(6/7) 
-1119 ATCRACAATTTATTTGTTCTCCCAACTATTGAGGCCACACACTTTTTGGGTGACTTAOTC 
e***tt* 
Tm'-RE (7/8) 
-1059  TGTGTAC  CTCAGACAAGGGCAAAACACGAGGCT  GAGCTGACTTTGGGGACCATGC  GAAGA 
NFg3(11/11)  GAS  (11/15) 
-999 TGAGTGGACC  C  TGGCAGGATGTGCTAGGGGGATTTTCCCT  C  TCTCTGTTTGTTCCTTTTC 
ISRE  (Ii/14) 
ISRE(10/14) 
-939 ~C~TA  ~'~12 ~"l~  ~T ~T ~r  C  ~T Gc  ~T GT  C~I'O~T  GC  T 
-879 TTATTGGAAGCATT  GTAAGAAATTATAATTTATTC  ~-A-A-A-A-A'~FFX~w~T  C  TC  AGAACAGG 
GAS(8/10) 
-819 GTTTTTCTGTGTAGTGTTCCTGGCTTATCCTAGAACTTACTC~__~_A~CAGGCTAGCC  C 
..r  7-ZRE(0/S) 
-759  AAACTCAGGGA~CTTTCTCTGTCTCCTGAATCC  C  GGOATTAAAGGCTTATGCCAC  C 
-699  ACACCCAGGTACC3~CATTATAATCCTATATATAAGAAGTCACCCACACATACAAACACAC 
-639 ACACACCACACACACACACACACACACACACACACACACAGAGAGAGAGAGAGAGAGAGA 
-579 GAGGGAGAGAGAGA~agGAGAGAGAGAATGC CACTGAGAAAAAARATAA~AAGGCTT  CACT 
AP-I(6/7)  ~r 
-519 CAGCACAGCCCATC  CACTATTCTGCCCAAGCTGAe  .C~.  t  ACTXCTAGTGGGGAAATGCTGGT 
"%9  ~ 
-339  GCCAGAGAGCTCCGTGCCCAGAACAAAATCCCTCAGCAGCTGCAAGC  CAGGGTATGTGGT 
-279  ~aa~.~v~c~cTc  CC~CCCTAGmOA~CCCX~C~aC ~C 
7-1aZCT/e)  7-Iasc7/8> 
X box(8111) 
-219 TGCCTAGGOGCCACTGCCTTGGAC~OGAAGAGATOO~~TAC 
y-IRE(7/8) 
7-IRE(7/8)  TNF-RE(7/8) 
-159  AC  CACAGAGTGATGTAA,~"CAAGCACACAGACTAGGAGTGTC  CATCATGAATGAGCTAACT 
v 
NF~(II/ll) 
-99  +I~  4~  T  GCACAC  C  ~~  C  C  ~"IN~d2d~CA~I~AT  ~21~I~TA~  T  ~1~ 
7-IRE1718) 
-39 ~TACCTGATGGCTGCTGCCAGGGTCACAACTTTACAGGGAGTTGAA 
7-IRE(718) 
+61 
+22  GACTGAGACTCTGGCCCCACGGGACACAGT  GTCACTGGTTTOAAACTTCTCAGCCACCTT 
GGGGTGCCCTGTGTCRCAGTGACCA~-  5  ' (26-mer) 
+8a GGTGAAGGGACTGAGCTGTTAGA ACA TTCTGAGGCTCCTCACGCTTGGGTCTTGTTCA 
+161 
+142 CTCCACGGAGTAGCCTAGT~actgcaag( intron 1 )agaacggagaacgttgga~ 
Hinr 
~tggag~agaagtgcaaa~c~cagaca~u 
susceptible to formation of Z-DNA  and  sometimes confer- 
ring enhancer activity (33) occupied positions  -  1314 to  -  1245 
and  -645  to  -600. 
The whole 1,749-bp region, as in pliNOS-CAT,  conferred 
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Figure  1.  (.4) The 5'-flanking  region of iNOS.  The nucleotide sequence 
(numbered left) of the 1,749-bp region (-1588 to  +161) is shown (upper 
case). The sequence (lowercase) following position +161 is from the cDNA 
ofiNOS (2). Intron 1 is inserted at the parentheses (personal communica- 
tion, Dr. J. Mudgett); the start codon for iNOS (~g) is in the second 
exon. A complementary sequence (italics) with 5'-end at +61 specifies the 
primer used for Fig. 2. (Bent  arrow) The mRNA initiation site (+1); (boxed) 
TATA sequence.  Elements are designated  that  are homologous to con- 
sensus sequences for binding of transcription factors involved in confer- 
ring responsiveness to cytokines or LPS in other genes, with the homology 
ratios in parentheses: (horizontal underlined arrows) 7-IRE; (starred) AP-1; 
(double underlined) TNF-ILE; (overlined) NF-xB; (underlined) ISILE; (over- 
lined arrow) GAS; (triple underlined) X  box. (Vertical  arrows) Restriction sites. 
(These sequence data are available from GenBank under accession number 
L09126).  (B) CAT constructs.  (Dashed  lines) Deleted portions. 
inducibility by LPS, along with synergistic responsiveness to 
the combination  of IFN-7 plus LPS.  The downstream  one 
third, as in p2iNOS-CAT,  contained a promoter responsive 
to LPS but unresponsive to the synergizing effect of IFN-7. 
Figure  2.  Determination of mR.NA initiation site for iNOS transcript. 
The 26-mer indicated in Fig. 1 A was used for the sequence ladders (lanes 
G, A,  T, and C). The same 26-met was also used in primer extension 
after labeling the 5'-end. Single-stranded DNA complementary to nucleo- 
tides  -300 to  +61 was labeled at the same Y-end and used in $1 nuclease 
mapping. (Lanes 1 and 2) $1 mapping with total RNA from RAW 264.7 
cells, without (lane 1) or with (lane 2) prior treatment  of the cells for 
8 h with IFN-7 (50 U/ml) and LPS (1/~g/ml). (Lanes 3-6) Primer exten- 
sion using RNA from RAW 264.7 cells (lanes 3 and 4) or from primary 
macrophages (lanes 5 and 6). The cells had been treated with (lanes 3 and 
5) or without (lanes 4 and 6) IFN-7 and LPS (8 h for RAW 264.7 cells; 
15 h  for primary macrophages). 
1781  Xie et al.  Brief Definitive Report Table  1.  Inducibility  of iNOS Promoter by LPS plus IFN-T 
No.  of  LPS phs  Fold 
Plasmid  Expts.  IFN-?  Acetylation  induction 
% 
pliNOS-CAT  8  -*  0.25  _+  0.03t 
+  10.94  _+  2.31  44 
pCAT-Basic  5  -  0.19  _+  0.05 
+  0.19  _+  0.03  1 
* LPS  (1  /zg/ml)  plus  IFN-')" (50 U/ml). 
t CAT activity in each transfectant  is expressed  as percent  acetylation 
of chloramphenicol  when 4 #g cell lysate protein was assayed at 37~ 
for 2  h  (mean  +  SEM). 
The critical contribution of the upstream portion for respon- 
siveness to IFN-'), may relate to its content of four ~/-IRE, 
all of which match the consensus sequence perfectly (8/8). 
By contrast, the downstream half of the 1,749-bp fragment 
contains six ',/-IRE, but each matches the consensus sequence 
less well (7/8). The upstream half also contains two ISRE 
lacking from the downstream half; two GAS (11/15, 8/10) 
versus one (7/10) in the downstream half; and one site each 
homologous  to NF-gB, AP-1, and TNF-RE. Yet the upstream 
half tested alone (construct p5iNOS-CAT)  was devoid of pro- 
moter activity,  with or without LPS plus IFN-y (data not 
shown). 
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Figure  4.  Concentration dependence of activation of iNOS promoter 
by LPS, and interaction  with IFN-% CAT activity in RAW 264.7 cells 
transfected with (A) pliNOS-CAT, (B) p2iNOS-CAT, or (C) p3iNOS- 
CAT. In each case, transfected cells were treated with the indicated con- 
centrations  of LPS with (Q) or without (O) IFN-3" (50 U/ml). CAT ac- 
tivity was measured as described in Table 1. In each panel, all treatments 
were carried  out with cells from the same transfected pool. 
Figure  3.  Demonstration of iNOS promoter activity.  The construct 
pliNO$-CAT  (lanes I and 2) or the vector itself, pCAT-Basic  (lanes 3 and 
4), was transfected into RAW 264.7 cells. The cells were cultured in the 
absence (lanes 1 and 3) or presence (lanes 2 and 4) of IFN-31 (50 U/ml) 
and LPS (1 #g/ml). Cell lysates were then assayed for CAT and the ethyl 
acetate extract of the reaction mixture subjected to TLC followed by auto- 
radiography. 
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RAW 264.7 macrophage-like cells have been a useful tool 
for transfection with reporter constructs to demonstrate pro- 
moter activity in genes that are inducible in macrophages 
(34, 35). Both RAW 264.7 cells (2, 4, 13) and primary mac- 
rophages (14-16) produce iNOS when treated with combi- 
nations of cytokines and LPS. However,  RAW 264.7  cells 
do not perfectly mirror the patterns of induction seen with 
primary mouse peritoneal macrophages. RAW 264.7  cells 
produce NO after exposure to LPS alone (13), whereas pri- 
mary mouse peritoneal macrophages do so little or not at 
all (15). Conversely, primary mouse peritoneal macrophages 
respond to IFN-'),  alone by producing NO  (15), but early 
passage RAW 264.7 cells do not (our unpublished observa- 
tions). Thus, a full analysis of synergistic induction and sup- 
pression of/NOS will require transfection of promoter-reporter 
constructs into additional cell types, including primary mac- 
rophages. 
Perhaps the best understood example of transcriptional in- 
duction by IFN-3/involves a primary response gene coding 
for a guanylate binding protein of unknown function (28, 
36, 37). The GAS in the guanylate binding protein promoter 
binds a 91-kD protein termed ")'-activated  factor (GAF). GAF 
has recently been cloned by virtue of its participation in the 
heterotetrameric transcription complex activated by IFN-cz (38). After treatment of human fibroblast FS2 cells with ei- 
ther IFN-3, or IFN-c~, GAF is phosphorylated on tyrosine 
and translocates to the nucleus (39). Our preliminary experi- 
ments (data not shown) suggest that tyrosine phosphoryla- 
tion may also participate in the induction of iNOS.  GAF 
or a similar protein may undergo IFN-3,-induced tyrosine 
phosphorylation in the cytoplasm, translocate to the nucleus, 
and induce the expression of a transcription factor that binds 
the iNOS promoter. LPS may synergize with IFN-q/by aug- 
menting this pathway, or by activating or inducing a distinct 
transcription factor(s) that may cooperate with proteins that 
bind the iNOS promoter in response  to IFN-% 
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